Harris, Julian A.
Faust, Bryan
Gondin, Arisbel B. http://orcid.org/0000-0002-1751-4062
Dämgen, Marc André http://orcid.org/0000-0002-8229-7906
Suomivuori, Carl-Mikael http://orcid.org/0000-0002-2445-8791
Veldhuis, Nicholas A.
Cheng, Yifan http://orcid.org/0000-0001-9535-0369
Dror, Ron O. http://orcid.org/0000-0002-6418-2793
Thal, David M. http://orcid.org/0000-0002-0325-2524
Manglik, Aashish http://orcid.org/0000-0002-7173-3741
Funding for this research was provided by:
National Science Foundation (2034836)
Human Frontier Science Program (LT000916/2018-L)
Department of Education and Training | Australian Research Council (DE170100152)
Howard Hughes Medical Institute
U.S. Department of Health & Human Services | National Institutes of Health (S10OD020054, S10OD021741, R01GM127359, DP5OD023048, U24 GM129541)
Department of Health | National Health and Medical Research Council (APP1138448, APP1196951)
Pew Charitable Trusts
Esther A. and Joseph Klingenstein Fund
Kinship Foundation
Article History
Received: 7 May 2021
Accepted: 27 August 2021
First Online: 28 October 2021
Competing interests
: Research in N.A.V.’s laboratory is funded, in part, by Takeda Pharmaceuticals and Endosome Therapeutics.